AVITA Medical Appoints New CMO, Elects Directors
Ticker: AVHHL · Form: 8-K · Filed: Jun 6, 2024 · CIK: 1762303
| Field | Detail |
|---|---|
| Company | Avita Medical, Inc. (AVHHL) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $87,500, $37,500 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-election, stockholder-meeting
TL;DR
AVITA Medical just named a new CMO and added two directors to the board.
AI Summary
AVITA Medical, Inc. announced on June 5, 2024, the appointment of Dr. Michael W. Ryan as Chief Medical Officer and the election of Ms. Jennifer L. Johnson and Mr. David M. D. Smith to its Board of Directors. The company also reported on the outcome of its Annual Meeting of Stockholders held on June 5, 2024, where proposals related to director elections and advisory votes on executive compensation were approved.
Why It Matters
These executive and board changes could signal a shift in the company's strategic direction and leadership focus, potentially impacting its future product development and market performance.
Risk Assessment
Risk Level: medium — Changes in key leadership and board composition can introduce uncertainty regarding future strategy and execution.
Key Numbers
- 001-39059 — Commission File Number (AVITA Medical's SEC filing identifier)
Key Players & Entities
- AVITA Medical, Inc. (company) — Registrant
- Dr. Michael W. Ryan (person) — Appointed Chief Medical Officer
- Ms. Jennifer L. Johnson (person) — Elected to Board of Directors
- Mr. David M. D. Smith (person) — Elected to Board of Directors
- June 05, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. Michael W. Ryan has been appointed as the new Chief Medical Officer.
Who were elected to the Board of Directors?
Ms. Jennifer L. Johnson and Mr. David M. D. Smith were elected to the Board of Directors.
When was the Annual Meeting of Stockholders held?
The Annual Meeting of Stockholders was held on June 5, 2024.
What were the main items voted on at the Annual Meeting?
The main items voted on included the election of directors and advisory votes on executive compensation.
What is AVITA Medical's state of incorporation?
AVITA Medical, Inc. is incorporated in Delaware.
Filing Stats: 912 words · 4 min read · ~3 pages · Grade level 11.1 · Accepted 2024-06-06 16:39:30
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share RCEL The Nasdaq Stock Mar
- $87,500 — estricted stock units equal in value to $87,500 (at the time of the grant) and the gran
- $37,500 — rant of stock options equal in value to $37,500 (at the time of the grant) to each of t
Filing Documents
- rcel-20240605.htm (8-K) — 102KB
- 0000950170-24-069945.txt ( ) — 220KB
- rcel-20240605.xsd (EX-101.SCH) — 25KB
- rcel-20240605_htm.xml (XML) — 5KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. At the Annual Meeting, the Company's stockholders voted on the proposals summarized in the Proxy Statement as set forth below: 1. Election of Directors (Proposal 1) . All seven directors named in the Proxy Statement were elected to serve on the Company's Board of Directors with the following vote: Name Votes For Votes Withheld Broker Non-Votes Mr. Louis Panaccio 9,639,179 3,437,336 2,141,804 Mr. James Corbett 12,007,045 1,243,405 2,141,804 Mr. Jeremy Curnock Cook 12,084,039 1,165,850 2,141,804 Professor Suzanne Crowe 12,341,978 908,472 2,141,804 Ms. Jan Stern Reed 11,611,092 1,635,332 2,141,804 Mr. Robert McNamara 12,261,891 988,559 2,141,804 Mr. Cary Vance 12,261,730 988,720 2,141,804 2. Appointment of Independent Auditor (Proposal 2) . The stockholders ratified the selection of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. The votes regarding this proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 14,794,234 206,185 366,332 - 3. Issuance of Securities to Non-Executive Directors (Proposals 3 - 8) : Stockholders approved the grant of restricted stock units equal in value to $87,500 (at the time of the grant) and the grant of stock options equal in value to $37,500 (at the time of the grant) to each of the six non-executive directors on the terms and conditions set out in the Proxy Statement. The votes regarding these proposals were as follows: Votes For Votes Against Abstentions Broker Non-Votes Mr. Louis Panaccio 10,834,366 1,947,210 446,306 2,138,869 Professor Suzanne Crowe 10,848,440 1,915,747 463,695 2,138,869 Mr. Jeremy Curnock Cook 10,834,337 1,948,061 445,484 2,138,869 Ms. Jan Stern Reed 10,696,549 2,082,094 449,239 2,138,869 Mr. Robert McNamara 10,837,227
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVITA Medical, Inc. Date: June 6, 2024 By: /s/ Donna Shiroma Donna Shiroma General Counsel